CALGARY, Alberta, Oct. 01, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) is pleased to announce the appointment of Ryan Kubik, CPA, CFA, ICD.D, as an independent member of the Company’s Board of Directors (the “Board”), effective October 1, 2026.
Originally published via Source Article.
VANCOUVER, British Columbia, Sept. 30, 2026 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) (“Asante” or the “Company”) announces that the senior lenders under its Senior Facilities Agreement and Mezzanine Facility Agreement, its stream purchaser and its hedge counterparty have agreed waivers and amendments to the Company’s financing arrangements, including extensions to two previously disclosed deadlines under its Senior Facilities Agreement.
Originally published via Source Article.
VANCOUVER, British Columbia, Sept. 30, 2026 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) (“Asante” or the “Company”) announces that the senior lenders under its Senior Facilities Agreement and Mezzanine Facility Agreement, its stream purchaser and its hedge counterparty have agreed waivers and amendments to the Company’s financing arrangements, including extensions to two previously disclosed deadlines under its Senior Facilities Agreement.
Originally published via Source Article.
VANCOUVER, British Columbia, Sept. 30, 2026 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) (“Asante” or the “Company”) announces that the senior lenders under its Senior Facilities Agreement and Mezzanine Facility Agreement, its stream purchaser and its hedge counterparty have agreed waivers and amendments to the Company’s financing arrangements, including extensions to two previously disclosed deadlines under its Senior Facilities Agreement.
Originally published via Source Article.
VANCOUVER, British Columbia, Sept. 30, 2026 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) (“Asante” or the “Company”) announces that the senior lenders under its Senior Facilities Agreement and Mezzanine Facility Agreement, its stream purchaser and its hedge counterparty have agreed waivers and amendments to the Company’s financing arrangements, including extensions to two previously disclosed deadlines under its Senior Facilities Agreement.
Originally published via Source Article.
EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) — Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today announces the change of its Chief Executive Officer (CEO). Effective November 23, 2026, Dr. Madi Madiyalakan will be retiring from his position as Quest’s CEO. Dr. Madiyalakan has been the CEO of Quest since August 2006. Mr. Jeffrey Shon, a director of Quest, will be taking over the role of CEO. Mr. Shon has considerable experience in the areas of legal, regulatory and corporate affairs, including venture capital funding focused on emerging technologies.
Originally published via Source Article.
MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. BioSyent ranked 343 on the list based on its three-year revenue growth of 54% (2022 – 2025) and is listed in the ‘Consumer’ category.
Originally published via Source Article.
MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. BioSyent ranked 343 on the list based on its three-year revenue growth of 54% (2022 – 2025) and is listed in the ‘Consumer’ category.
Originally published via Source Article.
MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. BioSyent ranked 343 on the list based on its three-year revenue growth of 54% (2022 – 2025) and is listed in the ‘Consumer’ category.
Originally published via Source Article.
MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. BioSyent ranked 343 on the list based on its three-year revenue growth of 54% (2022 – 2025) and is listed in the ‘Consumer’ category.
Originally published via Source Article.
